Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Theraloc

(THAYR-uh-lok)

A substance being studied in the treatment of some types of cancer. Theraloc binds to a protein called epidermal growth factor receptor (EGFR), which is found on some normal cells and some types of cancer cells. Blocking this protein may help keep cancer cells from growing. Theraloc is a type of monoclonal antibody. Also called nimotuzumab.

Theraloc

Search NCI's Dictionary of Cancer Terms